Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
The greatest show on Earth
What Senator Sanders and others always fail to bring to bear on these pricing discussions is the downstream cost of reduced hospitalisation and death as a result of these vaccines.
Latest news
-
Too much success
Too successful. Whether you think it is justified or not, Humira’s huge, persistent sales have become a stick with which to beat pharmaceutical companies’ pricing policies and patenting strategies. ... We saw similar enraged responses, despite its
-
AstraZeneca's Lynparza recommended by NICE for breast and prostate cancer
process. "Innovative oncology medicines such as olaparib often show effectiveness across multiple different cancer types and, in these situations, it’s essential that we continue to advance pricing and reimbursement pathways
-
Outsmarting unpredictability: using scenario planning to keep ahead
The scramble was inefficient, disconnected and stressful, and it has led to our current ‘post COVID’ reality, which presents more new challenges across many areas, from backlogs to pricing.
-
Sanofi to cut US insulin prices by up to 78% in January 2024
Other states including Minnesota, Mississippi, Arkansas and Kansas, as well as groups of drug purchasers, have previously brought legal action over insulin pricing.
-
Novo Nordisk to cut US insulin prices by up to 75% in January 2024
the pricing of their products. ... Other states including Minnesota, Mississippi, Arkansas and Kansas, as well as groups of drug purchasers, have previously brought legal action over insulin pricing.
More from news
Approximately 110 fully matching, plus 925 partially matching documents found.
Latest Intelligence
-
A new age of innovation in healthcare
Since then we have had to deal with the anti-vax movement – and drug pricing will continue to be an issue – but I believe that we need to continue to focus
-
Assessing the impact of rarity on French HTA and pricing decisions
An interesting example of the importance of eligible patient number in pricing negotiations in France is Kalydeco. ... unmet need, the existence of a clinical or pricing comparator therapy and the robustness of clinical evidence.
-
Are smart deals a clever solution to UK market access?
In 2021, 16 pricing and access deals were struck with the NHS, ten of which can be considered ‘smart’ – a new record for the UK, made even more impressive against the ... This value can be further established via RWE, and, in the meantime, the
-
Building a brighter future with patient support programmes
value-based pricing, it also makes sense to invest in an economic evaluation.
-
Health technology assessments: understanding the global landscape and considerations for drug development
Accordingly, companies are broadening their early health economics and outcomes research (HEOR), pricing and market access research initiatives and investment on a global scale. ... This list of country-level nuances only scratches the surface. Still, it
More from intelligence
Approximately 16 fully matching, plus 200 partially matching documents found.
Latest appointments
-
New faces at Lucid Group and ZPB Associates
Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
Both O’Leary and Massey have experience of delivering evidence-based pricing and market access communications to help build global brands.
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.
-
BMS appoints new commercial leader, Davies joins Eisai and more
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
More from appointments
Approximately 2 fully matching, plus 31 partially matching documents found.
Latest from PMHub
-
The challenges of reimbursement and innovative pricing for cell and gene therapies
The cell and gene therapy landscape is difficult to navigate when it comes to pricing and reimbursement. ... To solve this challenge, manufacturers are exploring novel models of pricing and payment with payers.
-
VPAS: The importance of making the right arguments, even in challenging times
With key workers’ strikes, inflation, and immense pressure on public services, arguing for a more generous pricing settlement for the pharmaceuticals industry could not be tougher. ... The environment to argue for a more generous settlement for industry
-
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence.
-
Pharmaceutical Marketing Strategies For The Digital Age
There are key trends shaping pharmaceutical marketing, such as the emphasis on patient engagement and education, sharing of scientific evidence, and a focus on value-based pricing. ... There are key trends shaping pharmaceutical marketing, such as an
-
ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY
Patient experience data which complements clinical data is a key element of patient focused drug development, filing submissions, pricing negotiations and healthcare technology assessments worldwide.
More from PMHub
Approximately 10 fully matching, plus 77 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
